ALYQ Trademark

Trademark Overview

On Wednesday, November 8, 2017, a trademark application was filed for ALYQ with the United States Patent and Trademark Office. The USPTO has given the ALYQ trademark a serial number of 87676268. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 29, 2025. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The ALYQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders
alyq

General Information

Serial Number87676268
Word MarkALYQ
Filing DateWednesday, November 8, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 29, 2025
Registration Number5734762
Registration DateTuesday, April 23, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 17, 2017
Primary Code005
First Use Anywhere DateWednesday, February 6, 2019
First Use In Commerce DateWednesday, February 6, 2019

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Friday, November 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 21, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 11, 2017NEW APPLICATION ENTERED
Wednesday, February 21, 2018ASSIGNED TO EXAMINER
Wednesday, February 21, 2018NON-FINAL ACTION WRITTEN
Wednesday, February 21, 2018NON-FINAL ACTION E-MAILED
Thursday, July 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 15, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 8, 2019TEAS STATEMENT OF USE RECEIVED
Friday, February 8, 2019USE AMENDMENT FILED
Wednesday, February 27, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 4, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 4, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 18, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 19, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 23, 2019REGISTERED-PRINCIPAL REGISTER
Friday, August 29, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 29, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 29, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, April 23, 2025TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 23, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

alyq blood pressure disorders cardiovascular treatment preparations prevention pharmaceutical